Medcare Weight Loss Therapy

Medcare Weight Loss Therapy operates as a telehealth-focused clinic serving patients throughout Virginia, with Nurse Practitioner Bridgett Perry leading clinical services from Portsmouth, VA. The practice centers on evidence-based weight management using FDA-approved GLP-1 receptor agonists, alongside complementary services including suboxone-assisted treatment for opioid use disorder and medical cannabis certification evaluations. By combining metabolic medicine with addiction medicine expertise, Medcare addresses the complex relationship between weight, chronic pain, and substance dependence that many patients experience simultaneously.

The clinic's weight loss protocols utilize semaglutide and tirzepatide, two glucagon-like peptide-1 receptor agonists that have demonstrated significant efficacy in clinical trials for both glycemic control and weight reduction. Semaglutide therapy at Medcare follows evidence-based dosing schedules, typically starting at lower doses and titrating upward based on individual tolerance and response, while tirzepatide—a dual GIP/GLP-1 receptor agonist—offers an alternative mechanism for patients who may benefit from enhanced incretin activity. All peptide medications are sourced through a PCAB-accredited compounding pharmacy partner, ensuring pharmaceutical quality standards for sterility, potency, and consistency that meet or exceed FDA guidelines for compounded preparations. This accreditation provides patients with assurance that their medications undergo rigorous testing and quality control processes.

Bridgett Perry, the clinic's Nurse Practitioner, conducts comprehensive telehealth consultations that assess metabolic health markers, weight loss history, comorbid conditions, and lifestyle factors before recommending peptide therapy. Her approach integrates medication management with practical guidance on nutrition patterns, physical activity adaptation, and behavioral strategies that support long-term weight maintenance beyond the active treatment phase. For patients managing opioid dependence, Perry provides suboxone therapy consultations that can be coordinated with weight management goals, recognizing that metabolic dysfunction often accompanies chronic pain and substance use disorders. The medical cannabis certification service offers Virginia residents an additional pathway for managing conditions that may intersect with weight and metabolic health, including chronic pain, anxiety, and sleep disorders that can impair weight loss efforts.

Patients initiating care at Medcare Weight Loss Therapy begin with a telehealth intake appointment where Bridgett Perry reviews medical history, current medications, previous weight loss attempts, and specific health goals. This virtual consultation model eliminates travel requirements for Virginia residents across the state, from Virginia Beach and Norfolk to Richmond and beyond, making specialized peptide therapy accessible to patients in rural and suburban areas who might otherwise lack local access to GLP-1 treatments. Following the initial evaluation, patients receive a personalized treatment plan that may include peptide prescriptions, dosing instructions, injection technique education, and monitoring schedules for tracking weight changes and potential side effects. The clinic maintains ongoing communication through telehealth follow-ups, allowing for dose adjustments and troubleshooting as patients progress through their weight loss journey.

Medcare's telehealth-exclusive model reflects the evolving landscape of metabolic medicine, where virtual care has proven effective for weight management interventions that require regular monitoring but not in-person procedures. The clinic's PCAB-accredited pharmacy partnership ensures that patients receive pharmaceutical-grade compounded semaglutide and tirzepatide with proper handling, storage, and delivery protocols. For Portsmouth-area patients and Virginia residents seeking medical weight loss solutions that extend beyond basic diet counseling, Medcare Weight Loss Therapy provides access to the same peptide therapies used in academic medical centers and specialty endocrinology practices, delivered through a convenient telehealth platform that accommodates working professionals, parents, and individuals with mobility limitations. The integration of weight loss services with suboxone therapy and medical cannabis certification distinguishes the practice as a resource for patients managing multiple chronic conditions that intersect with metabolic health.